Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety study of Zuqamu Granules based on retrospective real-world data
ChiCTR2500114638Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Zuqamu Granules in Symptom relief, sponsored by Union Hospital. Primary endpoints: Incidence rate of adverse drug reactions caused by drug dependence and Factors influencing the incidence of adverse reactions. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Zuqamu Granules
03
Conditions
Symptom relief
Beyond the preview
Go deeper on ChiCTR2500114638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114638.